Lantern Pharma Inc Stock Quote | Stock Price for LTRN | FinancialContent Business Page
FinancialContent fully hosted finance channel
Source: financialcontent.com
📰 Lantern Pharma News
Page 7 - Lantern Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lantern Pharma. Real-time updates on events, politics, business and more.
Lantern Pharma Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report
DALLAS, TX / ACCESSWIRE / August 19, 2022 / RedChip Companies will air a new interview on Lantern Pharma Inc. (NASDAQ:LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial
San Antonio United States Johns Hopkins Exchange Commission On Ut Health Science Center Lantern Pharma Inc
Source: finanznachrichten.de
Lantern Pharma Inc. (NASDAQ:LTRN) Short Interest Update
Lantern Pharma Inc. (NASDAQ:LTRN – Get Rating) was the recipient of a large drop in short interest in the month of May. As of May 31st, there was short interest totalling 89,700 shares, a drop of 40.4% from the May 15th total of 150,500 shares. Currently, 1.2% of the shares of the company are short […]
United States Morgan Stanley Geode Capital Management Lantern Pharma Company Profile Get Rating America Corp Lantern Pharma Inc
Source: etfdailynews.com
GlobalData Plc: Big Data Crucial for Business Strategy
The global data and analytics market in the pharmaceutical sector was valued at $1.4 billion in 2020...
Source: globenewswire.com
Lantern Pharma to Host Virtual KOL Event on Glioblastoma Multiforme (GBM) with Collaborators from Johns Hopkins during Brain Tumor Awareness Month
/PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and...
Source: prnewswire.com
Lantern Pharma Inc. (LTRN) CEO Panna Sharma on Q1 2022 Results - Earnings Call Transcript
Lantern Pharma Inc. (NASDAQ:NASDAQ:LTRN) Q1 2022 Earnings Conference Call May 3, 2022 16:30 ET Company Participants Nicole Leber - Investor Relations Associate, Finance & Administrative...
Source: seekingalpha.com
Lantern Pharma Reports First Quarter 2022 Financial Results and Operational Highlights
RADR®, Lanterns proprietary A.I. and machine learning platform, has now surpassed 20 billion data points, enhancing its precision, insights, and capabilities...
United States Lesliew Kreis Jr Maria Maccecchini Nicole Leber Exchange Commission On University Of Texas Health Science Center San Antonio
Source: prnewswire.com
Lantern Pharma's Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern's Board of Directors
/PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (A.I.) and...
Source: prnewswire.com
Lantern Pharma to Report First Quarter 2022 Operating & Financial Results on May 3rd, 2022 at 4:30 p.m. ET
/PRNewswire/ -- Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (A.I.) and...
United States Nicole Leber Exchange Commission On Prnewswire Lantern Pharma Inc Securities Exchange Chief Executive Officer
Source: prnewswire.com
Lantern Pharma Interview to Air on Bloomberg U.S. on the RedChip Money Report
ORLANDO, FL / ACCESSWIRE / April 14, 2022 / RedChip Companies, Inc. today announced that Lantern Pharma (NASDAQ:LTRN),a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence
United States Redchip Companies Inc Redchip Companies Lantern Pharma Redchip Money Report Chip Companies
Source: finanznachrichten.de